《默沙东Merck ＆ Co. Inc.（MRK）2022年财报「NYSE」（英文版）（36页）.pdf》由会员分享，可在线阅读，更多相关《默沙东Merck ＆ Co. Inc.（MRK）2022年财报「NYSE」（英文版）（36页）.pdf（36页珍藏版）》请在三个皮匠报告上搜索。

1、Merck Q4 2022 EarningsFebruary 2,2023Agenda2Strategy and Business UpdateRob DavisChairman and Chief Executive OfficerQuestion&Answer SessionBusiness/Financial Results and OutlookCaroline LitchfieldChief Financial OfficerResearch UpdateDr.Dean LiPresident,Merck Research LaboratoriesForward-looking st

2、atement of Merck&Co.,Inc.,Rahway,N.J.,USA3This presentation of Merck&Co.,Inc.,Rahway,N.J.,USA(the“company”)includes“forward-looking statements”within the meaning of the safe harbor provisions of the U.S.Private Securities Litigation Reform Act of 1995.These statements are based upon the current beli

3、efs and expectations of the companys management and are subject to significant risks and uncertainties.There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful.If underlyin

4、g assumptions prove inaccurate or risks or uncertainties materialize,actual results may differ materially from those set forth in the forward-looking statements.Risks and uncertainties include but are not limited to,general industry conditions and competition;general economic factors,including inter

5、est rate and currency exchange rate fluctuations;the impact of the global outbreak of novel coronavirus disease(COVID-19);the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally;global trends toward health care cost containment;technologi

6、cal advances,new products and patents attained by competitors;challenges inherent in new product development,including obtaining regulatory approval;the companys ability to accurately predict future market conditions;manufacturing difficulties or delays;financial instability of international economi